Compare Bangun Karya Perkasa Jaya Tbk. (KRYA) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bangun Karya Perkasa Jaya Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Bangun Karya Perkasa Jaya Tbk. trades at Rp67 (market cap 111.48B, 20.86M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Bangun Karya Perkasa Jaya Tbk. and Organon Pharma Indonesia Tbk. are close in size by market cap. Which is the better fit depends on your goals.
| KRYA | SCPI | |
|---|---|---|
Market Cap | 111.48B | 104.4B |
Volume | 20.86M | — |
Lot | 208.55K | — |
Turnover | 1.39B | — |
Average Price | 66.8 | — |
Value | 1.39B | — |
Indicative Equilibrium Price | 67 | — |
Indicative Equilibrium Volume | 1.5K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bangun Karya Perkasa Jaya Tbk.
PT Bangun Karya Perkasa Jaya Tbk (the "Entity") was established based on a Notarial Deed No. 2 dated January 7, 2007, of Ranti Nursukma H, S.H., Notary in Surabaya. The Entity started commercial operations in 2007.
Read more on KRYA →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
